HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by GoalVest Advisory LLC

GoalVest Advisory LLC increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 83.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 395 shares of the company’s stock after purchasing an additional 180 shares during the period. GoalVest Advisory LLC’s holdings in HCA Healthcare were worth $132,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of HCA. Stone House Investment Management LLC acquired a new stake in HCA Healthcare during the third quarter worth about $25,000. Centerpoint Advisors LLC purchased a new position in HCA Healthcare during the fourth quarter worth about $27,000. Atlantic Edge Private Wealth Management LLC purchased a new position in HCA Healthcare during the fourth quarter worth about $27,000. Bruce G. Allen Investments LLC purchased a new position in HCA Healthcare during the fourth quarter worth about $28,000. Finally, Rise Advisors LLC purchased a new position in HCA Healthcare during the first quarter worth about $36,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the stock. Wells Fargo & Company raised their price objective on shares of HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a research note on Thursday, March 28th. Barclays raised their price objective on shares of HCA Healthcare from $356.00 to $367.00 and gave the company an “overweight” rating in a research note on Monday, April 29th. TD Cowen decreased their price target on shares of HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a research note on Tuesday, April 30th. JPMorgan Chase & Co. lifted their price target on shares of HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a research note on Thursday, May 30th. Finally, Royal Bank of Canada lifted their price target on shares of HCA Healthcare from $322.00 to $329.00 and gave the stock an “outperform” rating in a research note on Monday, April 29th. Four equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $325.59.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $343.43 on Friday. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $343.73. The company has a debt-to-equity ratio of 29.26, a quick ratio of 1.02 and a current ratio of 1.16. The company’s fifty day moving average is $324.71 and its two-hundred day moving average is $316.70. The firm has a market capitalization of $89.95 billion, a P/E ratio of 17.12, a PEG ratio of 1.58 and a beta of 1.69.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 26th. The company reported $5.36 EPS for the quarter, topping the consensus estimate of $5.01 by $0.35. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The business had revenue of $17.34 billion for the quarter, compared to analyst estimates of $16.81 billion. During the same period in the previous year, the firm earned $4.93 EPS. The business’s revenue for the quarter was up 11.2% compared to the same quarter last year. Analysts forecast that HCA Healthcare, Inc. will post 20.92 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.77%. The ex-dividend date of this dividend is Friday, June 14th. HCA Healthcare’s payout ratio is 13.16%.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 1,600 shares of the company’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $309.00, for a total transaction of $494,400.00. Following the completion of the transaction, the executive vice president now owns 34,124 shares of the company’s stock, valued at approximately $10,544,316. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, EVP Michael S. Cuffe sold 6,311 shares of the stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $316.88, for a total transaction of $1,999,829.68. Following the completion of the transaction, the executive vice president now directly owns 29,624 shares in the company, valued at approximately $9,387,253.12. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Michael S. Cuffe sold 1,600 shares of the stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $309.00, for a total value of $494,400.00. Following the transaction, the executive vice president now owns 34,124 shares of the company’s stock, valued at $10,544,316. The disclosure for this sale can be found here. In the last quarter, insiders sold 12,397 shares of company stock valued at $3,921,929. 1.60% of the stock is owned by insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.